Volume 22, Issue 4, Pages (April 2014)

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells  Sugiko Watanabe, Yasuaki Ueda, Shin-ichi Akaboshi,
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Volume 16, Issue 3, Pages (March 2008)
Volume 131, Issue 4, Pages (October 2006)
Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry  Alexandra A. Mourad-Zeidan,
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,
Volume 20, Issue 4, Pages e4 (April 2017)
Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin 
Volume 133, Issue 1, Pages (July 2007)
CD74 induces TAp63 expression leading to B-cell survival
Volume 128, Issue 1, Pages (January 2005)
Generic and Personalized RNAi-Based Therapeutics for a Dominant-Negative Epidermal Fragility Disorder  Deena M. Leslie Pedrioli, Dun Jack Fu, Emilio Gonzalez-Gonzalez,
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 16, Issue 1, Pages (January 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 8, Issue 6, Pages (December 2005)
Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma
Volume 19, Issue 4, Pages (April 2011)
Volume 131, Issue 4, Pages (October 2006)
Yuen Yee Cheng, PhD, Michaela B
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 21, Issue 6, Pages (June 2013)
Volume 87, Issue 2, Pages (February 2015)
Volume 17, Issue 12, Pages (December 2009)
Volume 22, Issue 10, Pages (October 2014)
Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity  Tina.
Molecular Therapy - Nucleic Acids
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Volume 75, Issue 12, Pages (June 2009)
Volume 21, Issue 12, Pages (December 2013)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 26, Issue 1, Pages (January 2018)
Volume 20, Issue 12, Pages (December 2012)
Volume 43, Issue 5, Pages (September 2011)
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Molecular Therapy - Nucleic Acids
Volume 15, Issue 5, Pages (May 2007)
Multiple Functions of the 37/67-kd Laminin Receptor Make It a Suitable Target for Novel Cancer Gene Therapy  Jonathan Scheiman, Jen-Chieh Tseng, Yun Zheng,
Volume 138, Issue 4, Pages (April 2010)
Molecular Therapy - Nucleic Acids
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Reduced Expression of Connective Tissue Growth Factor (CTGF/CCN2) Mediates Collagen Loss in Chronologically Aged Human Skin  TaiHao Quan, Yuan Shao, Tianyuan.
Volume 19, Issue 8, Pages (August 2011)
The p73 Gene Is an Anti-Tumoral Target of the RARβ/γ-Selective Retinoid Tazarotene  Marina Papoutsaki, Mauro Lanza, Barbara Marinari, Steven Nisticò, Francesca.
Barbara Marinari, Costanza Ballaro, Maranke I
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 26, Issue 8, Pages (August 2018)
LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition  Huazhang Wu, Ying.
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 18, Issue 3, Pages (March 2010)
Volume 21, Issue 1, Pages (January 2013)
Molecular Therapy - Nucleic Acids
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Volume 23, Issue 4, Pages (April 2015)
Molecular Therapy - Nucleic Acids
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 24, Issue 10, Pages (October 2016)
Volume 38, Issue 1, Pages (April 2010)
Jiamiao Lu, Feijie Zhang, Mark A Kay  Molecular Therapy 
Volume 22, Issue 9, Pages (September 2014)
Volume 72, Issue 2, Pages (July 2007)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
NF-κB activation is required for EMT and metastasis.
Volume 26, Issue 3, Pages (March 2018)
Volume 19, Issue 2, Pages (February 2011)
Volume 23, Issue 4, Pages (April 2015)
Presentation transcript:

Volume 22, Issue 4, Pages 743-751 (April 2014) Targeting Estrogen-Related Receptor Alpha Inhibits Epithelial-to-Mesenchymal Transition and Stem Cell Properties of Ovarian Cancer Cells  Sophia SN Lam, Abby SC Mak, Judy WP Yam, Annie NY Cheung, Hextan YS Ngan, Alice ST Wong  Molecular Therapy  Volume 22, Issue 4, Pages 743-751 (April 2014) DOI: 10.1038/mt.2014.1 Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 ERRα induces EMT in ovarian cells. (a) OVCAR-3 cells transfected with empty vector pcDNA3.1 or ERRα construct or (b) SKOV-3 cells transfected with NS siRNA or ERRα siRNA for 24 hours were fixed and assessed for morphologic changes consistent with EMT. Left, the presence of spindle-shaped cells with loss of epithelial cell morphology was noted in ERRα-overexpressing and NS siRNA–treated cells. Right, scattered colonies were scored. Inset, whole-cell lysates were analyzed for the levels of ERRα by western blot analysis. (c) Expression of the epithelial cell molecule E-cadherin and expression of mesenchymal marker N-cadherin were assessed by western blotting. β-actin was included as a loading control. The band intensities were quantified by densitometric analysis and expression levels relative to that of β-actin are indicated. Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. *P < 0.05, compared with pcDNA3.1 or NS siRNA. Bar = 50 µm. EMT, epithelial–mesenchymal transition; ERRα, estrogen-related receptor alpha; NS, nonspecific; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 ERRα induces the expression of Snail. (a) OVCAR-3 cells were transfected with empty vector pcDNA3.1 or ERRα construct or (b) SKOV-3 cells were transfected with nonspecific (NS) siRNA or ERRα siRNA for 24 hours. Total RNA was extracted and reverse transcription–polymerase chain reaction was performed using sequence-specific primers to ERRα, Snail, and Slug. β-actin was included as an internal control. The signal intensities were quantified by densitometric analysis and the amount was normalized for the amount of β-actin. Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. *P < 0.05, compared with pcDNA3.1 or NS siRNA. ERRα, estrogen-related receptor alpha; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 ERRα activates the promoter of Snail and attenuates its mRNA degradation. (a) OVCAR-3 cells were transiently transfected with 1.5 µg of the Snail promoter and 15 ng of β-galactosidase plasmid for 24 hours. Luciferase and β-galactosidase activities were assayed, and the luciferase activity of each sample was normalized with β-galactosidase activity. The luciferase activity was calculated relative to that with promoter alone, which was arbitrarily assigned a value of one. (b) OVCAR-3 cells transfected with the empty vector pcDNA3.1 or ERRα construct or (c) SKOV-3 cells transfected with nonspecific (NS) siRNA or ERRα siRNA were incubated with actinomycin D (ActD; 5 µg/ml) over a time course of 0, 1, 2, 4, and 6 hours. Total RNA was then extracted and reverse transcription–polymerase chain reaction was performed using Snail sequence–specific primers. β-actin was included as an internal control. The signal intensities were quantified by densitometric analysis, and the amount was normalized for the amount of β-actin. Results are presented as the mean ± SD and were analyzed using Kruskal–Wallis test followed by Dunn's test for post hoc analysis. *P < 0.05, compared with pcDNA3.1. ERRα, estrogen-related receptor alpha; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 ERRα-induced EMT requires miR-200 family members. SKOV-3 cells were transfected with NS siRNA or ERRα siRNA for 24 hours. Total RNA was extracted and reverse transcription–polymerase chain reaction was performed using sequence-specific primers to miR-141, miR-200a, miR-200b, and miR-200c. U6 was included as an internal control. The signal intensities were quantified by densitometric analysis and the amount was normalized for the amount of U6. Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. *P < 0.05, compared with NS siRNA. EMT, epithelial–mesenchymal transition; ERRα, estrogen-related receptor alpha; NS, nonspecific; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 ERRα-induced EMT requires miR-200 family members. (a) SKOV-3 cells were transfected with nonspecific (NS) siRNA or ERRα siRNA in combination with NS miRNA, anti-miR-200a, or anti-miR-200b for 24 hours. Morphologic changes were assessed by light microscopy (upper) and scattered colonies were scored (lower). (b) Total RNA was extracted and reverse transcription–polymerase chain reaction was performed using sequence-specific primers to Snail. β-actin was included as an internal control. The signal intensities were quantified by densitometric analysis and the amount was normalized for the amount of β-actin. Results are presented as the mean ± SD and were analyzed using Kruskal–Wallis test followed by Dunn's test for post hoc analysis. *P < 0.05, compared with NS siRNA. Bar = 50 µm. EMT, epithelial–mesenchymal transition; ERRα, estrogen-related receptor alpha; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Knockdown of ERRα inhibits CSC phenotype. (a) SKOV-3 cells were transfected with nonspecific (NS) siRNA or ERRα siRNA for 72 hours. The number of tumor spheres generated was photographed (left) and counted (right). Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. (b) Total RNA was extracted and reverse transcription–polymerase chain reaction was performed using sequence-specific primers to Nanog, Oct-4, and Bmi-1. β-Actin was included as an internal control. The signal intensities were quantified by densitometric analysis and the amount was normalized for the amount of β-actin. Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. (c) The number of tumor spheres generated was photographed (left) and counted (right). Bar = 50 µm. Results are presented as the mean ± SD and were analyzed using Kruskal–Wallis test followed by Dunn's test for post hoc analysis. *P < 0.05; **P < 0.01, compared with NS siRNA. Bar = 50 µm. CSC; cancer stem cells; ERRα, estrogen-related receptor alpha; siRNA, small interfering RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 ERRα knockdown inhibits peritoneal dissemination of ovarian cancer cells in vivo. (a) NOD/SCID mice were orthotopically injected with SKOV-3 cells transduced by nonspecific (NS) shRNA or ERRα shRNA (three mice per group). At the time of sacrifice, bioluminescence imaging was again performed, and the peritoneal cavity was assessed for evidence of metastases. (b) Ascites fluid was collected and the volume was measured. (c) The metastatic lesions were excised and their total number was counted. Results are presented as the mean ± SD and were analyzed using Mann–Whitney U-test. ERRα, estrogen-related receptor alpha; NOD/SCID, nonobese diabetic/severe combined immunodeficient; shRNA, short hairpin RNA. Molecular Therapy 2014 22, 743-751DOI: (10.1038/mt.2014.1) Copyright © 2014 The American Society of Gene & Cell Therapy Terms and Conditions